New Jersey bio-science company Zymes has announced that it has found a new way of solubilising fish oil and Omega-3 fatty acids in pure water.
The company claims that its solubilisation technology, known as Ubisol-Aqua, provides a superior platform for solubilising Omega-3 fatty acids and other water-insoluble lipophilic compounds for foods, beverages, nutritional supplements, pharmaceuticals and cosmetics.
The technology, which is available for licensing, provides improved solubility, enhanced bioavailability and particle size reduction to the nanometer level, Zymes said, adding that the development of Ubisol-Aqua marks another major breakthrough for the many industries looking to supplement their products with functional ingredients.
To achieve solubilisation, Ubisol-Aqua uses nanotechnology and complexation to reformulate and improve solubility of drugs, nutrient and cosmetic ingredients that are water-insoluble and therefore difficult for the human body to absorb.
“Achieving solubility of fish oil and Omega-3 fatty acids creates additional opportunities to bring our Ubisol-Aqua technology to the food, beverage and nutritional markets around the world,” said Benjamin D. Mamola, co-founder and executive vice president of global business development at Zymes. “Our new breakthrough technology makes it possible to more effectively deliver Omega-3 fatty acids in foods and beverages. We believe the technology will greatly enhance the health benefits of these products to consumers.”
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
